MedPath

The Impact of a Moderate Carbohydrate Diet in Children With Type 1 Diabetes on Hybrid Closed-loop Therapy

Not Applicable
Recruiting
Conditions
Diabetes Mellitus, Type 1
Interventions
Other: Moderate carbohydrate diet
Other: Traditional diet
Registration Number
NCT06567158
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

In the past, carbohydrate restriction was indicated as a treatment for people with type 1 diabetes when exogenous insulin was not available. Now it is mainly used as an added treatment for people with type 1 diabetes on top of standard insulin administration and glucose monitoring. Despite previous studies, the impact of carbohydrate restriction on glycemic control and quality of life is still not clear. Furthermore, few studies exist on carbohydrate restriction in children with type 1 diabetes and combined with the use of hybrid closed-loop insulin delivery. Therefore this study will determine the impact on glycemic control and the feasability of a moderate carbohydrate diet compared to a traditional diet in children (7-17 years) with type 1 diabetes on top of using a hybrid closed-loop system. In this randomized, crossover study, 28 children will follow a moderate carbohydrate diet (four weeks) and a traditional diet (four weeks) in randomized order. With a run-in period (two weeks) prior to the first diet and a wash-out period (six weeks) between the two diets, the children will participate in the study for a total of 16 weeks. The primary endpoint is the difference of time spent in target range (defined as a sensor glucose value between 70 and 180 mg/dL) between the four-week moderate carbohydrate diet and the four-week traditional diet.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Signed informed consent (ICF) (both children/adolescents and parents)
  • ≥7 and ≤17 years old at moment of ICF signature
  • ≥6 months type 1 diabetes diagnosis at moment of ICF signature
  • ≥3 months use of the hybrid closed-loop system Medtronic MiniMedTM 780G, Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature
  • Ability to understand, read, write and speak Dutch, French or English at moment of ICF signature
Exclusion Criteria
  • <7 or >17 years old at moment of ICF signature
  • <6 months type 1 diabetes diagnosis at moment of ICF signature
  • <3 months use of the advanced hybrid closed-loop system Medtronic MiniMedTM 780G, Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature
  • Any other insulin therapy than advanced hybrid closed-loop system Medtronic MiniMedTM 780G , Tandem t:slim X2 Control-IQTM or Mylife Ypsopump with CamAPS algorithm at moment of ICF signature
  • Failure to understand, read, write or speak Dutch, French or English at moment of ICF signature

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Group 1: 1st Traditional diet, 2nd Moderate carbohydrate dietModerate carbohydrate dietThe group that starts with the traditional diet in the first 4-week diet period. After wash-out, this group will start with the moderate carbohydrate diet in the second 4-week diet period.
Group 2: 1st Moderate carbohydrate diet, 2nd Traditional dietTraditional dietThe group that starts with the traditional diet in the first 4-week diet period. After wash-out, this group will start with the moderate carbohydrate diet in the second 4-week diet period.
Group 2: 1st Moderate carbohydrate diet, 2nd Traditional dietModerate carbohydrate dietThe group that starts with the traditional diet in the first 4-week diet period. After wash-out, this group will start with the moderate carbohydrate diet in the second 4-week diet period.
Group 1: 1st Traditional diet, 2nd Moderate carbohydrate dietTraditional dietThe group that starts with the traditional diet in the first 4-week diet period. After wash-out, this group will start with the moderate carbohydrate diet in the second 4-week diet period.
Primary Outcome Measures
NameTimeMethod
Time in range4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of time spent in range (70-180 mg/dL) between the moderate carbohydrate diet and the traditional diet.

Secondary Outcome Measures
NameTimeMethod
Time in tight range4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of time spent in range (70-140 mg/dL) between the moderate carbohydrate diet and the traditional diet.

Time above range4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of time spent above range (\>180 mg/dL) between the moderate carbohydrate diet and the traditional diet.

Daily insulin dose4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of insulin doses (total, basal and bolus) between the moderate carbohydrate diet and the traditional diet.

Time in level 2 hyperglycemia4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of time spent above range of 250 mg/dL between the moderate carbohydrate diet and the traditional diet.

Hemoglobin A1c4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of hemoglobin A1c between the moderate carbohydrate diet and the traditional diet.

Meal composition4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in meal composition a between the moderate carbohydrate diet and the traditional diet.

Time in level 2 hypoglycemia4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of time spent below range of 54 mg/dL between the moderate carbohydrate diet and the traditional diet.

Satisfaction with the diet in the context of diabetes treatment4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in the satisfaction with the diet (Diabetes treatment satisfaction questionnaire - DTSQs) between the moderate carbohydrate diet and the traditional diet. The DTSQs has a scale of 0-48 and a higher score is associated with a higher treatment satifaction.

Number of severe hypoglycemic events4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in the frequency of severe hypoglycemic events between the moderate carbohydrate diet and the traditional diet.

Time below range4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of time spent below range (\<70 mg/dL) between the moderate carbohydrate diet and the traditional diet.

Mean blood glucose4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of mean blood glucose between the moderate carbohydrate diet and the traditional diet.

Number of diabetic ketoacidosis4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in the frequence of diabetic ketoacidosis between the moderate carbohydrate diet and the traditional diet.

Blood lipids (total cholesterol, triglycerides, high density lipoprotein and low density lipoprotein concentrations)4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in blood lipids (total cholesterol, triglycerides, high density lipoprotein and low density lipoprotein concentrations) between the moderate carbohydrate diet and the traditional diet.

Bioelectrical impedance analysis4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in bioelectrical impedance analysis between the moderate carbohydrate diet and the traditional diet.

Carb ratio4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in carb ratio between the moderate carbohydrate diet and the traditional diet.

Active insulin time4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in active insulin time between the moderate carbohydrate diet and the traditional diet.

Number of people who use glucose target 100 mg/dL, 110 mg/dL and 120 mg/dL4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in umber of people who use glucose target 100 mg/dL, 110 mg/dL and 120 mg/dL between the moderate carbohydrate diet and the traditional diet.

Glycemic variability: standard deviation and coefficient of variation4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference of glycemic variability, in terms of standard deviation (SD) and coefficient of variation (CV) of blood glucose levels between the moderate carbohydrate diet and the traditional diet.

Body mass index4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in body mass index between the moderate carbohydrate diet and the traditional diet.

Body weight4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in body weight between the moderate carbohydrate diet and the traditional diet.

Consumed carbohydrates4 weeks moderate carbohydrate diet and 4 weeks traditional diet

Difference in consumed carbohydrates between the moderate carbohydrate diet and the traditional diet.

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Vlaams-Brabant, Belgium

© Copyright 2025. All Rights Reserved by MedPath